Behind The Labs - Episode 52 - Vitamin C Vs. COVID-19, Microplastics Leading to Neurodegenerative Diseases, and Paternal Nicotine Exposure Effects Child Metabolic Health
In this episode of Behind the Labs, we explore several new studies that reveal how everyday exposures and biological processes can influence human health. We begin with the VIVID clinical trial, which tested whether high-dose vitamin D supplements could reduce the severity of COVID-19 or prevent infection within households. While the study found no meaningful effect on acute illness or transmission, researchers observed a possible small reduction in long-COVID symptoms among participants who closely followed the supplementation regimen. We also discuss research on paternal nicotine exposure, where scientists discovered that nicotine use in fathers before conception altered metabolic pathways in their offspring, suggesting that a father’s health habits may influence the long-term disease risk of future children.
The episode then shifts to environmental and neurological health, highlighting a systematic review suggesting that microplastics could contribute to neurodegenerative diseases such as Alzheimer’s and Parkinson’s through mechanisms like inflammation, oxidative stress, and mitochondrial dysfunction. We also cover a study showing that THC intoxication can significantly impair multiple types of memory, including prospective memory and source memory, even at moderate doses. Finally, we examine new research linking cellular energy metabolism to depression, where abnormal ATP production patterns may help explain fatigue and cognitive symptoms in patients, as well as a clinical trial showing that the drug sulthiame may reduce breathing interruptions in obstructive sleep apnea, offering a potential alternative treatment to CPAP machines. Together, these studies highlight how advances in biomedical research continue to uncover unexpected connections between environment, behavior, and disease.